Anhydroicaritin

CAS No. 38226-86-7

Anhydroicaritin( —— )

Catalog No. M18495 CAS No. 38226-86-7

Anhydroicaritin exhibits immunosuppressive effect on the mouse macrophages stimulated by LPS.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 42 In Stock
10MG 72 In Stock
25MG 138 In Stock
50MG 205 In Stock
100MG 318 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Anhydroicaritin
  • Note
    Research use only, not for human use.
  • Brief Description
    Anhydroicaritin exhibits immunosuppressive effect on the mouse macrophages stimulated by LPS.
  • Description
    Anhydroicaritin exhibits immunosuppressive effect on the mouse macrophages stimulated by LPS. Anhydroicaritin phytosomes can inhibit enhanced bone turnover induced by ovariectomy, improve BMD the biomechanical properties of vertebrae, without any stimulation on uterus. Anhydroicaritin possesses significant protective effects on the zymosan-induced peritonitis mice, which might be associated with the regulation of Ca(2+); influx in macrophages and iNOS expression.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    38226-86-7
  • Formula Weight
    368.38
  • Molecular Formula
    C21H20O6
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 8.33 mg/mL (22.61 mM)
  • SMILES
    CC1(CCC2=C3C(=C(C=C2O1)O)C(=O)C(=C(O3)C4=CC=C(C=C4)OC)O)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Auranofin

    Auranofin is an antirheumatic agent, is used to treat rheumatoid arthritis.

  • CCG-63802

    CCG-63802 is a reversible small-molecule inhibitor of regulator of G protein signaling (RGS) proteins.

  • TPCK

    TPCK is an irreversible inhibitor of chymotrypsin-like proteases that affect cell proliferation apoptosis and tumorigenesis.